Quantitative Systematic Strategies LLC Rocket Pharmaceuticals, Inc. Transaction History

Quantitative Systematic Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$43.34 - $65.91 $255,055 - $387,880	-5,885 Reduced 35.12%	10,873 $482,000
Q4 2020 Feb 09, 2021	SELL	$23.3 - $59.57 $27,587 - $70,530	-1,184 Reduced 6.6%	16,758 $919,000
Q3 2020 Nov 09, 2020	SELL	$20.5 - $28.59 $222,835 - $310,773	-10,870 Reduced 37.73%	17,942 $410,000
Q2 2020 Aug 04, 2020	BUY	$13.32 - $22.61 $192,287 - $326,397	14,436 Added 100.42%	28,812 $603,000
Q1 2020 May 06, 2020	SELL	$9.71 - $25.11 $161,118 - $416,650	-16,593 Reduced 53.58%	14,376 $201,000
Q4 2019 Feb 11, 2020	BUY	$11.07 - $24.23 $138,585 - $303,335	12,519 Added 67.85%	30,969 $705,000
Q3 2019 Nov 07, 2019	BUY	$10.85 - $14.78 $7,009 - $9,547	646 Added 3.63%	18,450 $215,000
Q2 2019 Jul 25, 2019	BUY	$15.0 - $19.81 $267,060 - $352,697	17,804 New	17,804 $267,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.